These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34884258)

  • 21. Parenteral and Oral Anticoagulant Treatment for Hospitalized and Post-Discharge COVID-19 Patients: A Systematic Review and Meta-Analysis.
    Tunjungputri RN; Tetrasiwi EN; Mulansari NA; Harimurti K; Nelwan EJ
    Acta Med Indones; 2022 Apr; 54(2):190-209. PubMed ID: 35818663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
    ; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
    JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation outcomes in hospitalized Covid-19 patients: A systematic review and meta-analysis of case-control and cohort studies.
    Kamel AM; Sobhy M; Magdy N; Sabry N; Farid S
    Rev Med Virol; 2021 May; 31(3):e2180. PubMed ID: 33022834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials.
    Kow CS; Ramachandram DS; Hasan SS
    J Infect Chemother; 2022 Feb; 28(2):257-265. PubMed ID: 34840039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboprophylaxis With Apixaban in Patients Undergoing Major Orthopedic Surgery: Meta-Analysis and Trial-Sequential Analysis.
    Caldeira D; Rodrigues FB; Pinto FJ; Ferreira JJ; Costa J
    Clin Med Insights Blood Disord; 2017; 10():1179545X17704660. PubMed ID: 28579855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis.
    Bosch FTM; Mulder FI; Kamphuisen PW; Middeldorp S; Bossuyt PM; Büller HR; van Es N
    Blood Adv; 2020 Oct; 4(20):5215-5225. PubMed ID: 33104795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.
    Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P
    Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and Efficacy of Intermediate- and Therapeutic-Dose Anticoagulation for Hospitalised Patients with COVID-19: A Systematic Review and Meta-Analysis.
    Reis S; Popp M; Schmid B; Stegemann M; Metzendorf MI; Kranke P; Meybohm P; Weibel S
    J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of venous thromboembolism with new oral anticoagulants versus standard pharmacological treatment in acute medically ill patients: a systematic review and meta-analysis.
    Albertsen IE; Larsen TB; Rasmussen LH; Overvad TF; Lip GY
    Drugs; 2012 Sep; 72(13):1755-64. PubMed ID: 22876779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Comparison of Therapeutic With Prophylactic Anticoagulation on Mortality, Risk of Bleeding, and Thromboembolism in Hospitalized Patients With COVID-19: A Systematic Review.
    Kham NI; Shahid R; Naik SS; Ramphall S; Rijal S; Prakash V; Ekladios H; Mulayamkuzhiyil Saju J; Mandal N; Balani P
    Cureus; 2022 Oct; 14(10):e29932. PubMed ID: 36381788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and Efficacy of Different Anticoagulant Doses for Patients with COVID-19 in the ICU: A Systematic Review and Meta-Analysis.
    Rachina S; Belkova Y; Shchendrygina A; Suvorov A; Bourgeois D; Karuk M; Sitnikova V; Dyatlov N
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer.
    Wang Y; Wang M; Ni Y; Liang Z
    Hematology; 2020 Dec; 25(1):63-70. PubMed ID: 31984870
    [No Abstract]   [Full Text] [Related]  

  • 34. Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
    Beitland S; Sandven I; Kjærvik LK; Sandset PM; Sunde K; Eken T
    Intensive Care Med; 2015 Jul; 41(7):1209-19. PubMed ID: 25971389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia.
    Hsu A; Liu Y; Zayac AS; Olszewski AJ; Reagan JL
    Thromb Res; 2020 Dec; 196():375-378. PubMed ID: 32980620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effectiveness and safety of thromboprophylaxis in cancer patients based on Khorana score: a meta-analysis and systematic review of randomized controlled trials.
    Bao Y; Gao B; Yan P; Tian L; Yang K
    Clin Transl Oncol; 2020 Nov; 22(11):1992-2001. PubMed ID: 32246324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of direct oral anticoagulants for extended duration thromboprophylaxis in medically ill patients: a systematic review and meta-analysis.
    Alshouimi RA; Al Rammah SM; Alzahrani MY; Badreldin HA; Al Yami MS; Almohammed OA
    J Thromb Thrombolysis; 2019 Oct; 48(3):422-429. PubMed ID: 31222563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulation for people with cancer and central venous catheters.
    Akl EA; Ramly EP; Kahale LA; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Oct; (10):CD006468. PubMed ID: 25318061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer.
    Carrier M; Khorana AA; Moretto P; Le Gal G; Karp R; Zwicker JI
    Am J Med; 2014 Jan; 127(1):82-6.e1. PubMed ID: 24384102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and Efficacy of Enoxaparin in Pregnancy: A Systematic Review and Meta-Analysis.
    Jacobson B; Rambiritch V; Paek D; Sayre T; Naidoo P; Shan J; Leisegang R
    Adv Ther; 2020 Jan; 37(1):27-40. PubMed ID: 31673991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.